ARK Genomic Revolution ETF (BATS:ARKG) Stock Price Up 1.3% – Time to Buy?

ARK Genomic Revolution ETF (BATS:ARKGGet Free Report) shares traded up 1.3% on Monday . The company traded as high as $30.57 and last traded at $29.91. 2,307,531 shares were traded during mid-day trading, a decline of 17% from the average session volume of 2,781,392 shares. The stock had previously closed at $29.54.

ARK Genomic Revolution ETF Stock Performance

The company’s 50-day moving average price is $28.22 and its 200-day moving average price is $29.52.

Institutional Trading of ARK Genomic Revolution ETF

A number of institutional investors have recently bought and sold shares of the business. Sunbelt Securities Inc. increased its holdings in shares of ARK Genomic Revolution ETF by 734.3% in the 3rd quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock valued at $31,000 after acquiring an additional 984 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new stake in shares of ARK Genomic Revolution ETF during the 2nd quarter worth about $38,000. AlphaCore Capital LLC purchased a new stake in ARK Genomic Revolution ETF during the fourth quarter worth approximately $39,000. Hilton Head Capital Partners LLC lifted its stake in ARK Genomic Revolution ETF by 161.4% during the first quarter. Hilton Head Capital Partners LLC now owns 1,537 shares of the company’s stock worth $41,000 after purchasing an additional 949 shares during the last quarter. Finally, Wealth Watch Advisors INC boosted its holdings in ARK Genomic Revolution ETF by 274.4% in the fourth quarter. Wealth Watch Advisors INC now owns 1,928 shares of the company’s stock valued at $56,000 after purchasing an additional 1,413 shares in the last quarter.

About ARK Genomic Revolution ETF

(Get Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

Recommended Stories

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.